Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(t18:0/24:0)(2-)

Term ID

CHEBI:65201

Synonyms

(2S,3S)-3,4-dihydroxy-2-(tetracosanoylamino)octadecyl (1R,2R,3R,4R,5S,6R)-2,3,4,5-tetrahydroxy-6-{[6-O-({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphinato)-beta-D-mannopyranosyl]oxy}cyclohexyl phosphate

Definition

An inositol phosphomannosylinositol phosphophytoceramide(2-) having a tetracosanoyl group attached to the ceramide nitrogen, hydroxylation at C-4 of the long-chain base, and no additional hydroxylation of the very-long-chain fatty acid.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: inositol phosphomannosylinositol phosphophytoceramide(2-)

inositol phosphomannosylinositol phosphophytoceramide(2-) Show first 5 Terms
inverse is_conjugate_acid_of: Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(t18:0/24:0)

Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(t18:0/24:0) Show first 5 Terms
is_conjugate_base_of: Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(t18:0/24:0)

Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(t18:0/24:0) Show first 5 Terms

Phenotype

Phenotype resulting from Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(t18:0/24:0)(2-)

Phenotype where environments contain Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(t18:0/24:0)(2-)

Phenotype modified by environments containing Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(t18:0/24:0)(2-)

Human Disease Model